Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TP53RK Antibody | Login | TP53RK Antibody | ||||||||||||||||
|
||||||||||||||||||
| IL31 Antibody | Login | IL31 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ABI2 Antibody | Login | ABI2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| KAT6A Antibody | Login | KAT6A Antibody | ||||||||||||||||
|
||||||||||||||||||
| ACSS1 Antibody | Login | ACSS1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ANGPT1 Antibody | Login | ANGPT1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| AQP1 Antibody | Login | AQP1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CHD1 Antibody | Login | CHD1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CLCA1 Antibody | Login | CLCA1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CYP2A6 Antibody | Login | CYP2A6 Antibody | ||||||||||||||||
|
||||||||||||||||||
| DLX5 Antibody | Login | DLX5 Antibody | ||||||||||||||||
|
||||||||||||||||||
| FUT3 Antibody | Login | FUT3 Antibody | ||||||||||||||||
|
||||||||||||||||||
| eNOS Antibody | Login | eNOS Antibody | ||||||||||||||||
|
||||||||||||||||||
| TAS2R38 Antibody | Login | TAS2R38 Antibody | ||||||||||||||||
|
||||||||||||||||||
| PTGFR Antibody | Login | PTGFR Antibody | ||||||||||||||||
|
||||||||||||||||||
| Adiponectin Receptor 1 Antibody | Login | Adiponectin Receptor 1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| p38 MAPK Antibody | Login | p38 MAPK Antibody | ||||||||||||||||
|
||||||||||||||||||
| HSPA1A Antibody [1B10F3] | Login | HSPA1A Antibody [1B10F3] | ||||||||||||||||
|
||||||||||||||||||
| MAP2K2 Antibody, KO Validated | Login | MAP2K2 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| MAP2K4 Antibody, KO Validated | Login | MAP2K4 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| PRDX4 Antibody, KO Validated | Login | PRDX4 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| DGKQ Antibody | Login | DGKQ Antibody | ||||||||||||||||
|
||||||||||||||||||
| DDB1 Antibody | Login | DDB1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| DYNC1I1 Antibody | Login | DYNC1I1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| FGL1 Antibody | Login | FGL1 Antibody | ||||||||||||||||
|
||||||||||||||||||


